Cargando…
The Interplay between Vitamin D, Exposure of Anticholinergic Antipsychotics and Cognition in Schizophrenia
Vitamin D deficiency is a frequent finding in schizophrenia and may contribute to neurocognitive dysfunction, a core element of the disease. However, there is limited knowledge about the neuropsychological profile of vitamin D deficiency-related cognitive deficits and their underlying molecular mech...
Autores principales: | Gaebler, Arnim Johannes, Finner-Prével, Michelle, Sudar, Federico Pacheco, Langer, Felizia Hannah, Keskin, Fatih, Gebel, Annika, Zweerings, Jana, Mathiak, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138360/ https://www.ncbi.nlm.nih.gov/pubmed/35625833 http://dx.doi.org/10.3390/biomedicines10051096 |
Ejemplares similares
-
Influence of Antipsychotic and Anticholinergic Loads on Cognitive Functions in Patients with Schizophrenia
por: Rehse, Michael, et al.
Publicado: (2016) -
Effects of antipsychotic and anticholinergic medications on cognition in chronic patients with schizophrenia
por: Haddad, Chadia, et al.
Publicado: (2023) -
Targeting Treatment-Resistant Auditory Verbal Hallucinations in Schizophrenia with fMRI-Based Neurofeedback – Exploring Different Cases of Schizophrenia
por: Dyck, Miriam S., et al.
Publicado: (2016) -
Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics
por: Hori, Hikaru, et al.
Publicado: (2022) -
Adding pre-emptive anticholinergics to antipsychotics: Is it justified?
por: Chatterjee, Kaushik, et al.
Publicado: (2022)